MedPath

A study on patients of shock due to infection and observing blood test value in predicting their outcome.

Not Applicable
Conditions
Health Condition 1: A419- Sepsis, unspecified organism
Registration Number
CTRI/2022/12/048102
Lead Sponsor
Fortis Escorts Heart Institute
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients >= 18 years of age.

2.Patients admitted with sepsis and septic shock as defined by treating physician.

Exclusion Criteria

1.Patients not in sepsis and septic shock.

2.Patients in shock other than septic shock.

3.Patients presented as symptoms or diagnosis of Tropical Fever (Fever with thrombocytopenia).

4.Patients presenting with SIRS but not sepsis like pancreatitis, Heat stroke, Neoplasia, chemical aspiration, Trauma.

5.Patients with disease like splenomegaly, ITP or drugs induced thrombocytopenia.

6.Patients having malignancies or autoimmune diseases or bone marrow suppression.

7.Patients not willing to give consent for the study.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Correlation of PLR with APACHE 2 in sepsis with septic shock.Timepoint: 24 hours
Secondary Outcome Measures
NameTimeMethod
To evaluate prognostic role of PLR in 28 day mortality outcome in sepsis with septic shock.Timepoint: 28 days
© Copyright 2025. All Rights Reserved by MedPath